100% Quality Guarantee
PhD-Level Technical Support
Key Features

FITC Anti-Human CD49d Antibody [9F10] (AGEL1736)

SKU AGEL1736
Product Type Antibody
Antibody Type Monoclonal Antibody
Reactivity Human
Applications FC
€113 - €413

Request a formal quotation

A PDF quote with its own quote number, ready for your purchasing office to raise a PO against. Back within 4 working hours, from a PhD scientist — not an autoresponder.

  • PO-ready PDFQuote number, VAT, Incoterms
  • Volume pricing appliedDiscounts from 2 kits up
  • Valid 30 daysPrices held while you get sign-off
Anything we should know? optional

No account needed. We use your details only to prepare and send this quote. If it's urgent, say so in the box and we'll come back the same working day.

Global Shipping: 80+ Countries
White Glove Service: Available upon request
Batch Consistency: Contact Sales
Distributors: 60+ Countries

Description

system_update_altDatasheetsystem_update_altMSDS

FITC Anti-Human CD49d Antibody [9F10]

The Human CD49d Monoclonal Antibody (FITC Conjugated, 9F10) is a cutting-edge tool designed for researchers studying cell adhesion and migration processes. This antibody specifically targets CD49d, a cell surface integrin involved in cell-to-cell and cell-to-matrix interactions, essential for various physiological and pathological processes.By utilizing the FITC conjugation, this antibody allows for fluorescent detection of CD49d in human samples, enabling precise visualization and analysis in flow cytometry and immunofluorescence experiments. The high specificity and sensitivity of the 9F10 antibody make it a reliable choice for investigating cell adhesion dynamics in diverse cell types and experimental settings.CD49d, also known as integrin alpha-4, plays a crucial role in leukocyte trafficking, inflammation, and immune responses.

Dysregulation of CD49d function has been implicated in various diseases, including inflammatory disorders, autoimmune conditions, and cancer metastasis. Therefore, a deeper understanding of CD49d biology is paramount for developing targeted therapies and interventions that modulate cell adhesion processes in disease settings.This FITC-conjugated monoclonal antibody represents a valuable tool for researchers seeking to elucidate the intricate mechanisms underlying cell adhesion mediated by CD49d, paving the way for novel insights into disease pathogenesis and therapeutic strategies aimed at modulating cell behavior.

View AllClose

0 Reviews

0
Based on 0 reviews

No reviews yet. Be the first to share your experience!

View AllClose